follow us:Google+ FacebookLinkedInTwitterRSS Feeds


Sales at Celgene rise 17 percent in second quarter


Back to Top Comments Email Print

News You Can Use

Latest News


Net product sales at pharmaceutical giant Celgene Corp. climbed to $1.56 billion in the second quarter of 2013, a 17 percent increase over the same period last year, according to the company's most recent earnings report.

In that same time, adjusted net income at the Summit-based company rose 20 percent, to $653 million. Total revenue also was up for the quarter, climbing to $1.59 billion, from $1.36 billion last year.

Celgene specializes in developing drugs to treat cancer and inflammatory diseases.

Reporter Mary Johnson is @mjohns422 on Twitter.

Share This Story On:

Write to the Editorial Department at



Be the first to comment.

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
Back to Top